<DOC>
	<DOCNO>NCT03051347</DOCNO>
	<brief_summary>This designated validate patient-reported outcome ( PRO ) measure itch-specific pediatric skin condition , atopic dermatitis , examine ability modify stigma instrument ass severity type stigma experience atopic dermatitis potentially stigmatizing condition .</brief_summary>
	<brief_title>Asthma Atopic Dermatitis Validation PROMIS Pediatric Instruments</brief_title>
	<detailed_description>This study involve series research development project target two common chronic disease affect child : asthma atopic dermatitis ( AD , eczema ) . The Investigators propose directly validate patient-reported outcome ( PRO ) measure large cohort itch-specific pediatric skin condition , primary focus AD . The Investigators propose examine ability PROMIS ( Patient-Reported Outcomes Measurement Information Systems ) instrument detect meaningful clinically significant change disease status , well create pediatric itch item pool PRO model sign symptom skin disease . The Investigators also examine ability modify Neuro-QOL stigma instrument ass severity type stigma experience AD across various dermatologic potentially stigmatize condition . Lurie Children 's Hospital involve AD stigma portion project</detailed_description>
	<mesh_term>Psoriasis</mesh_term>
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis , Atopic</mesh_term>
	<mesh_term>Eczema</mesh_term>
	<mesh_term>Ichthyosis</mesh_term>
	<criteria>Affected child must moderate severe AD another skin condition cause itch , experience itch , understand English , able complete Englishbased survey Any child potentially disfigure skin condition change appearance relate disease/intervention consider eligible . Parents child condition also ask participate . Children parent must also understand English able complete Englishbased survey</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>